Pelthos Therapeutics Files 8-K on Financials
Ticker: PTHS · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1919246
| Field | Detail |
|---|---|
| Company | Pelthos Therapeutics Inc. (PTHS) |
| Form Type | 8-K |
| Filed Date | Aug 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, corporate-actions
TL;DR
Pelthos Therapeutics (formerly Channel/Chromocell) dropped an 8-K on financials today - check it out.
AI Summary
Pelthos Therapeutics Inc. filed an 8-K on August 18, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements. The company, formerly known as Channel Therapeutics Corp and Chromocell Therapeutics Corp, is incorporated in Nevada and based in Durham, NC.
Why It Matters
This 8-K filing provides crucial updates on Pelthos Therapeutics' financial performance and operational status, which is important for investors to assess the company's current health and future prospects.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting financial results and does not appear to contain any immediately alarming or unusual information.
Key Players & Entities
- Pelthos Therapeutics Inc. (company) — Registrant
- Channel Therapeutics Corp (company) — Former Company Name
- Chromocell Therapeutics Corp (company) — Former Company Name
- August 18, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- Durham, NC (location) — Business Address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Pelthos Therapeutics Inc.'s Results of Operations and Financial Condition, as well as provide Regulation FD Disclosures and Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on August 18, 2025.
What were Pelthos Therapeutics Inc.'s former company names?
Pelthos Therapeutics Inc. was formerly known as Channel Therapeutics Corp (name change effective November 18, 2024) and prior to that, Chromocell Therapeutics Corp (name change effective March 23, 2022).
In which state is Pelthos Therapeutics Inc. incorporated?
Pelthos Therapeutics Inc. is incorporated in Nevada.
What is the business address of Pelthos Therapeutics Inc.?
The business address of Pelthos Therapeutics Inc. is 4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-08-18 08:05:50
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PTHS The NYSE American LL
Filing Documents
- g084926_8k.htm (8-K) — 43KB
- g084926_ex99-1.htm (EX-99.1) — 31KB
- image_002.jpg (GRAPHIC) — 4KB
- 0001753926-25-001353.txt ( ) — 251KB
- pths-20250818.xsd (EX-101.SCH) — 3KB
- pths-20250818_lab.xml (EX-101.LAB) — 33KB
- pths-20250818_pre.xml (EX-101.PRE) — 22KB
- g084926_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 18, 2025 Pelthos Therapeutics Inc. By: /s/ Francis Knuettel II Name: Francis Knuettel II Title: Chief Financial Officer